| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,469 |
BKI Announces 2025 Full Year Results
|
21 Jul 2025 9:11AM |
$1.795 |
$1.820 |
risen by
1.39%
|
|
BKI - Price-sensitive ASX Announcement
Full Release
Key Points
- BKI achieved growth in net tangible assets per share during the year.
- Steady dividend income was distributed to shareholders.
- The investment strategy remained focused on high-quality Australian listed securities.
- Disciplined portfolio management and diversification were maintained.
- Risk management practices were reinforced amid market volatility.
- BKI retained a strong balance sheet and sound liquidity position.
- The Board provided updates on corporate governance and activities.
- The economic environment, including interest rates, was discussed.
- Shareholder engagement was prioritized throughout the year.
- Sustainability and ESG initiatives were highlighted.
- The outlook for the coming year is cautiously optimistic, with a continued focus on delivering sustainable returns.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,469 |
BKI 2025 Corporate Governance Statement
|
21 Jul 2025 9:09AM |
$1.795 |
$1.820 |
risen by
1.39%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$41 |
Update - Notification of buy-back - MEC
|
21 Jul 2025 9:09AM |
$1.140 |
$1.350 |
risen by
18.42%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,469 |
BKI Appendix 4G for the year ended 30 June 2025
|
21 Jul 2025 9:09AM |
$1.795 |
$1.820 |
risen by
1.39%
|
|
| Salter Brothers Emerging Companies Limited (SB2) ORDINARY FULLY PAID |
Financials |
$47 |
Update - Notification of buy-back - SB2
|
21 Jul 2025 9:09AM |
$0.710 |
$0.560 |
fallen by
21.13%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,469 |
Dividend/Distribution - BKI
|
21 Jul 2025 9:09AM |
$1.795 |
$1.820 |
risen by
1.39%
|
|
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$789 |
Tivan and Sumitomo agree development pathway at Sandover
|
21 Jul 2025 9:09AM |
$0.084 |
$0.345 |
risen by
310.71%
|
|
TVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Tivan Limited and Sumitomo Metal Mining Oceania Pty Ltd have entered into an agreement for the development of the Sandover Project in the Northern Territory.
- The agreement includes a staged investment and a collaborative scoping study to define resources and evaluate processing options.
- Sumitomo will have an option to earn an additional interest in the Sandover Project through further investment.
- The Sandover Project is highlighted for its potential in vanadium, titanium, and iron resources.
- The partnership aims to advance project studies and development, leveraging Sumitomo's technical expertise and global standing.
- Tivan's strategy focuses on value creation through partnerships with leading global companies in the critical minerals sector.
- The agreement represents a key step in progressing the Sandover Project towards commercialisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$789 |
JOGMEC joins Speewah Fluorite Project joint venture
|
21 Jul 2025 9:09AM |
$0.084 |
$0.345 |
risen by
310.71%
|
|
TVN - Price-sensitive ASX Announcement
Full Release
Key Points
- JOGMEC has entered into a preliminary agreement to join the Speewah Fluorite Project joint venture.
- The project is located in Western Australia and is operated by Tivan Limited via its subsidiary TVN (Speewah) Pty Ltd.
- JOGMEC can earn an interest in the project by funding exploration and development activities.
- The partnership aims to accelerate development and commercialization of the fluorite resource.
- JOGMEC brings expertise and financial capacity to the project.
- The collaboration is expected to enhance access to Japanese markets for the fluorite product.
- This agreement reflects the strategic value of the Speewah project for both Tivan Limited and JOGMEC.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cleo Diagnostics Ltd (COV) ORDINARY FULLY PAID |
Health Care |
$68 |
Quarterly activities and cashflow report
|
21 Jul 2025 9:09AM |
$0.365 |
$0.495 |
risen by
35.62%
|
|
COV - Price-sensitive ASX Announcement
Full Release
Key Points
- Cleo Diagnostics progressed development and commercialisation of its COV ovarian cancer diagnostic test.
- Completed a clinical study and advanced regulatory submission processes for COV.
- Prepared for commercial launch of COV in Australia.
- Engaged with key opinion leaders and stakeholders for product adoption.
- Initiated activities for international expansion and regulatory approvals.
- Reported cash flows, expenditures, and confirmed sufficient funding for ongoing activities.
- Focused on building commercial partnerships and strategic collaborations.
- Cleo remains committed to bringing COV to market and improving ovarian cancer diagnostics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,469 |
BKI FY25 Preliminary Final Report & Annual Report
|
21 Jul 2025 9:08AM |
$1.795 |
$1.820 |
risen by
1.39%
|
|
BKI - Price-sensitive ASX Announcement
Full Release
Key Points
- BKI Investment Company Limited reported its financial results for the year ended 30 June 2024.
- The company maintained a diversified portfolio of Australian equities with an emphasis on long-term value creation.
- BKI’s dividend policy and consistent distributions to shareholders were highlighted.
- Prudent cost management and conservative capital allocation remain central to operational strategy.
- Key financial metrics including profit, earnings per share, and net tangible assets were disclosed.
- Director and management commentary addressed current year performance and future expectations.
- The report described governance practices and risk management frameworks in place.
- BKI addressed market conditions, economic challenges, and steps taken to sustain shareholder value.
- An outlook for the next financial year was provided, focusing on navigating uncertain markets.
- The annual report includes statutory disclosures, director reports, and audit statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$2,500 |
Change in substantial holding
|
21 Jul 2025 9:08AM |
$1.295 |
$16.250 |
risen by
1,154.83%
|
|
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$26 |
Change of Director's Interest Notice
|
21 Jul 2025 9:08AM |
$0.044 |
$0.021 |
fallen by
52.27%
|
|
| Veris Limited (VRS) ORDINARY FULLY PAID |
Industrials |
$32 |
Veris Awarded $16-$20m Suburban Rail Loop Contract
|
21 Jul 2025 9:08AM |
$0.058 |
$0.060 |
risen by
3.45%
|
|
VRS - Price-sensitive ASX Announcement
Full Release
Key Points
- Veris Limited announced a contract award for the Suburban Rail Loop project in Victoria.
- The contract value is between $16 million and $20 million.
- It is a four-year agreement with an optional two-year extension.
- Veris will provide surveying and spatial services for the project.
- The contract was awarded by the Victorian Government.
- The Suburban Rail Loop is a major Melbourne transport infrastructure project.
- Veris will deliver survey data, mapping, and spatial technology support.
- The contract is expected to positively impact Veris' revenue and growth.
- This project reinforces Veris' position as a leading surveying solutions company in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$11 |
Proposed issue of securities - DUN
|
21 Jul 2025 9:07AM |
$0.019 |
$0.046 |
risen by
142.11%
|
|
| Decidr AI Industries Ltd (DAI) ORDINARY FULLY PAID |
Consumer Staple |
$153 |
Notification of Expiry of Listed Options
|
21 Jul 2025 9:07AM |
$0.490 |
$0.435 |
fallen by
11.22%
|
|
| Stellar Resources Limited (SRZ) ORDINARY FULLY PAID |
Materials |
$102 |
June 2025 Quarterly Activities Report & Cashflow Report
|
21 Jul 2025 9:07AM |
$0.018 |
$0.030 |
risen by
66.67%
|
|
SRZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Stellar Resources Limited released its Quarterly Activities Report and Cashflow Report for the quarter ending June 2025.
- The Heemskirk Tin Project remains the company’s focus, with ongoing exploration and feasibility work.
- Significant progress was made on advancing the project’s permitting, environmental assessments, and technical studies.
- The company continued engagement with key stakeholders and government authorities to support project development.
- Cash outflows for the quarter were mainly attributed to exploration and evaluation expenditures.
- Stellar Resources reported its cash position at the end of the quarter and outlined expected cash outflows for the next quarter.
- No mining production or revenue was recorded during the quarter as the project is still in the development phase.
- The report included statements on compliance with ASX Listing Rules and confirmations regarding related party transactions.
- Stellar Resources aims to unlock value from the Heemskirk Tin Project and is actively seeking to progress toward project financing and development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$26 |
Cleansing Notice
|
21 Jul 2025 9:07AM |
$0.044 |
$0.021 |
fallen by
52.27%
|
|
| Iltani Resources Limited (ILT) ORDINARY FULLY PAID |
Materials |
$31 |
High-grade silver results received from resource drilling
|
21 Jul 2025 9:06AM |
$0.195 |
$0.390 |
risen by
100%
|
|
ILT - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade silver assay results received from resource drilling at the Orient Silver Project.
- Drilling targeted the Orient West and Orient East lodes.
- Multiple significant intersections confirm high-grade silver mineralisation.
- Results support the company's progress towards a maiden JORC mineral resource estimate.
- Additional mineralised zones identified, expanding the exploration potential.
- Drilling has improved geological understanding of the mineralised system.
- Results will inform future exploration and development activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elsight Limited (ELS) ORDINARY FULLY PAID |
Information Technology |
$1,785 |
Trading halt
|
21 Jul 2025 9:05AM |
$1.925 |
$8.050 |
risen by
318.18%
|
|
ELS - Price-sensitive ASX Announcement
Full Release
Key Points
- Elsight Limited (ELS) has requested a trading halt to be placed on its securities.
- The trading halt is due to a pending announcement regarding a proposed capital raising.
- The halt will remain until the earlier of normal trading on 13 June 2024 or the release of the announcement.
- The request was made to ensure the market is fully informed.
- Relevant correspondence between Elsight Limited and the ASX is included.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LGI Limited (LGI) ORDINARY FULLY PAID |
Utilities |
$274 |
FY25 Results Webinar Notification & 2025 AGM Date
|
21 Jul 2025 9:05AM |
$3.230 |
$2.650 |
fallen by
17.96%
|
|
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,902 |
Update on director relevant interest
|
21 Jul 2025 9:03AM |
$15.070 |
$12.850 |
fallen by
14.73%
|
|
| Elixir Energy Limited (EXR) ORDINARY FULLY PAID |
Energy |
$243 |
Quarterly Activities Report and Appendix 5B Jun 25
|
21 Jul 2025 9:02AM |
$0.029 |
$0.130 |
risen by
348.28%
|
|
EXR - Price-sensitive ASX Announcement
Full Release
Key Points
- EXR focused on gas exploration and appraisal in Mongolia's Nomgon IX CBM PSC.
- The company reported positive drilling and testing results, indicating potentially commercial gas flow rates.
- Progress continued on green hydrogen and renewable energy initiatives, including feasibility studies and partnerships.
- Ongoing discussions and engagement with Mongolian government authorities to secure project approvals and support.
- Financial data and cash flow disclosures are included through the Appendix 5B for the reporting quarter.
- Operational expenditures were detailed, reflecting investment in both exploration and project development.
- EXR's forward work programs remain focused on unlocking value from coal seam gas and renewable energy resources.
- The company highlighted its commitment to sustainable energy solutions and continued stakeholder engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$11 |
Proposed issue of securities - DUN
|
21 Jul 2025 9:02AM |
$0.019 |
$0.046 |
risen by
142.11%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$733 |
Weekly Estimate NTA for 18.07.2025
|
21 Jul 2025 9:01AM |
$3.020 |
$3.520 |
risen by
16.56%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$24 |
Final US FDA De Novo Clearance Submission Completed
|
21 Jul 2025 9:01AM |
$0.039 |
$0.115 |
risen by
194.87%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- PainChek Ltd has completed its final US FDA De Novo submission for its PCK product.
- PCK is an AI-driven medical device for pain assessment, particularly for individuals with communication difficulties.
- Final submission follows extensive clinical validation, technical development, and regulatory preparations.
- Achieving FDA De Novo clearance is expected to open the large US market to PainChek.
- The submission includes comprehensive technical, clinical, and safety evidence.
- PainChek’s solution addresses an unmet clinical need in pain management.
- Company plans to leverage its global market experience and US partnerships for commercial launch.
- Announcement marks a major milestone in PainChek's global expansion strategy.
- PainChek’s US regulatory pathway involves a rigorous review process with a focus on product safety and efficacy.
- The company expresses confidence in its product and regulatory submission, anticipating significant market impact upon approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
